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Abstract
Background: Renal Cell Carcinoma (RCC) metastasizes in approximately 20–30% cases. The most common sites for
metastases are the lungs, bones, liver, and brain. Metastases of RCC in the gastrointestinal tract (GIT) are very rare.
Metastatic RCC has a poor prognosis. We herein present a case series of three patients with metastatic disease in the
colon, duodenum, and pancreas following complete resection of RCC.
Methods: Hematoxylin and Eosin and immunohistochemical slides of 3 cases of RCC metastatic to GIT were
reviewed. These cases were diagnosed between 2002 and 2019 at French Medical Institute for Mothers and Children
(FMIC), Kabul, Afghanistan, and Aga Khan University Hospital (AKUH), Karachi, Pakistan. We also present a detailed
review of published literature.
Results: We reviewed cases of three patients, two females and one male, with a mean age of 57.3 years (range
40–67 years) who underwent nephrectomy for RCC. They developed metastases in the colon, pancreas, and duode‑
num, respectively 12–168 months (median time 156 months) following primary tumor resection. The patient with
metastatic RCC in colon presented with abdominal pain and constipation. An ulcerated mass was found on colonos‑
copy 30 cm from the anal verge. Diagnosis of RCC with rhabdoid features was confirmed in both primary and meta‑
static tumors. The second patient developed a metastatic nodule in the head of pancreatic while the third patient
developed metastatic nodules in the duodenum and pancreas which were detected by Computed Tomography (CT)
scanning. Histopathological examination confirmed the presence of clear cell RCC in the metastatic nodules in both
cases.
Conclusion: Metastatic RCC should be considered in the differential diagnosis of mass in the gastrointestinal
(including pancreaticobiliary) tract especially in presence of a past history of RCC. These patients should be screened
thoroughly by physical examination and appropriate imaging studies.
Keywords: Renal cell carcinoma, Clear cell, Rhabdoid, Metastasis, Pancreas, Colon
Background
Renal cell carcinoma (RCC) accounts 85% of renal neoplasms and 2% of all malignant neoplasm of the body.
Commonly RCC develops in the cortical region of the
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kidney. RCC is more common in males [1]. Among many
different histologic variants of RCC, clear cell RCC is
the most common histological type, around 75–80% of
RCCs cases [2]. Papillary and chromophobe RCC types
comprise approximately 10% and 5% of all RCC tumors,
respectively. Papillary and chromophobe RCC are less
aggressive while collecting duct carcinoma and unclassified RCC are rarer and more aggressive [3]. RCC with
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rhabdoid features generally are more aggressive with
rapid growing and causing high mortality rate. Studies found that median survival rates ranged from 8 to
31 months and metastasis occurs in up to 70% of rhabdoid cases [4–6]. Overall, RCC metastasize in approximately 25% cases. Lungs, bones, liver and brain are the
most frequent sites where RCCs are metastasizing. However, gastrointestinal tract (GIT) is not the common site
of metastatic RCCs and rarely reported [7]. RCC has the
potential to metastases to the distant organ after many
years [8]. Metastatic RCC has poor prognosis with a
5-year survival of 0–18% in patients with untreated metastatic disease [9]. Thomason et al. in 1991, reported the
first case of RCC metastasizing to colon and based on our
extensive literature review, to date 26 cases have been
reported in literature [10–35] (Table 1).
We present three cases with colonic, duodenal and
pancreatic metastases following complete resection of
RCC of clear cell and rhabdoid types.

Methods
The Surgical Pathology files of Section of Histopathology, Departments of Pathology and Clinical Laboratory, French Medical Institute for Mothers and Children
(FMIC) and Aga Khan University Hospital (AKUH) were
searched for cases of metastatic RCC reported between
2002 and 2019. The histological slides were reviewed by
two of the principal authors (JAG and NU). All Hematoxylin and Eosin (H&E) and immunohistochemical (IHC)
stained slides of the primary and metastatic tumors were
reviewed. Since this was a retrospective study involving review of H&E slides, chart review and analysis of
radiological findings, ethical approval was not sought.
Informed consent was obtained from patients in whom
follow up was available.
Result
A total 3 cases were reported, one case at FMIC and two
cases at AKUH.

Table 1 Reported cases of metastatic renal cell carcinoma in colorectum
Number cases [citation]

Age/sex

Symptoms

Site

Interval

Histology

1. Ruiz et al. [10]

73 Y/M

Obstruction

Transverse colon

11 years

Clear cell

2. Thomason et al. [11]

71 Y/M

Bowel changes habit

Descending colon

17 years

Clear cell

3. Zerbib et al. [12]

64 Y/M

Bleeding

Descending colon

At time of diagnosis

Clear cell

4. Tokonabe et al. [13]

83 Y/M

Melena

Transverse colon

7 years

Clear cell

5. Avital et al. [14]

72 Y/F

NM*

Right colon

5 years

Clear cell

6. Misu et al. [15]

67 Y/M

Constipation

Sigmoid colon

4 years

Clear cell

7. Sawh et al. [16]

53 Y/M

Pain and bleeding

Anus

9 years

Clear cell

8. Rosito et al. [17]

55 Y/M

Hematochezia

Distal rectum

9 months

Clear cell

9. Mori et al. [18]

71 Y/M

Fecal occult blood

Ascending colon

At time of diagnosis

Clear cell

10. Dellon et al. [19]

70 Y/M

Hematochezia

Rectum

NM

NM

11. Víctor Edmundo et al. [20]

60 Y/M

Hematochezia

Splenic flexure

8 years

Clear cell

12. Yetkin et al. [21]

60 Y/M

Dyspepsia and pain

Hepatic flexure

5 years

Clear cell

13. Jadav et al. [22]

67 Y/F

Abdominal pain

Transverse colon

9 years

Clear cell

14. Chetty [23]

92 Y/M

Asymptomatic

Ascending and sigmoid colon

17 years

Clear cell

15. Zhao et al. [24]

54 Y/M

Hematochezia

Ascending colon

At time of diagnosis

Chromophobe

16. Milović et al. [25]

63 Y/M

Bloating

Sigmoid colon

10 Months

NM

17. Tsamis et al. [26]

64 Y/M

Anemia

Ascending colon

5 Months

NM

18. Davies et al. [27]

76 Y/M

NM

Perianal

7 years

Clear cell

19. Elaine Vo et al. [28]

67 Y/M

Hematochezia

Rectosigmoid

9 years

Clear cell

20. Yuji Maehata et al. 2016 [29]

61 Y/M

hematochezia

Rectum

NM

Clear cell

21. Berry et al. [30]

75 Y/M

Abdominal pain

Sigmoid colon

At time of diagnosis

Papillary

22. Guoyang Zheng et al. [31]

65 Y/M

NM

Rectum

10 years

Clear cell

23. Simon Ouellet et al. [32]

78 Y/M

Painless bleeding

Rectum

NM

Clear cell

24. Valere et al. [33]

33 Y/F

Abdominal pain

Descending colon

3 years

Sarcomatoid

25. Subaşı et al. [34]

63 Y/M

hematochezia

Splenic flexure

5 years

Clear cell

26. Kataoka et al. [35]

65 Y/M

Hip joint pain

Ascending colon

1 year

Clear cell

27. Current case

46 Y/F

Pain and constipation

Descending colon

1 year

Rhabdoid RCC

*

NM not mentioned
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Case 1 A 40-year-old woman with a history of persistent abdominal pain and constipation along with
bleeding per rectum was referred by her physician to a
gastroenterologist at a private hospital. She had these
symptoms for three months. A colonoscopy examination was performed and revealed an ulcerated growth at
30 cm from the anal verge. A biopsy from the ulcerated
mass was performed during the colonoscopy procedure
and reported as hematoma. No dysplasia or malignancy
were observed. Patient gave history of radical nephrectomy one year ago performed at another private hospital. The nephrectomy specimen was diagnosed on
histopathological examination as urothelial carcinoma
in a private pathology laboratory. Gastroenterologist was
not satisfied with diagnosis and referred the patient to a
surgeon at his hospital. The patient underwent segmental
resection of the colon and specimen was sent to us for
histopathological examination. The specimen consisted
of a 54 cm segment of colon. On opening, an exophytic
mass with nodular surface measuring 11 × 6 × 4 cm
was seen in the distal portion of the segment (Fig. 1a).
Representative sections from the mass were submitted
for histopathological examination. On histopathological examination, sheets of large pleomorphic neoplastic
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cells with large amount eosinophilic cytoplasm, enlarged,
pleomorphic, hyperchromatic eccentric nuclei and visible nucleoli (rhabdoid pattern) were seen (Fig. 1b, c). In
areas, tumors cells showed an alveolar arrangement. The
classic histologic pattern of RCC was not observed. IHC
stains were performed on neoplastic cells and showed
positivity for cytokeratin (CK) AE1/AE3 and Cam 5.2,
SATB2, vimentin and PAX8 (Fig. 1d). The tumor cells
did not show reactivity with TFE3, desmin, MyoD1,
S100 protein, anti-smooth muscle actin (ASMA), HMB45, Melan A, CK7, CK20, CDX2, CD34, CD117, synaptophysin, and Hepar-1. Based on above IHC staining
profile a final diagnosis of RCC with rhabdoid features
metastasizing to colon was rendered. Tissue slides of the
previous nephrectomy specimen were also re-evaluated,
and the microscopic findings concur with diagnosis of
RCC with rhabdoid features. The pathological stage of
radical nephrectomy was pT2aNxMx with tumor size
of 7.5 cm in the greatest dimension. Patient died of disease 4 months after the diagnosis of colonic metastasis of
RCC.
Case 2 A 67-year-old woman visited our hospital
with complain of persistent abdominal pain. Her Computed Tomography (CT) scan findings showed a mass

Fig. 1 Grossly after opening of the segment of rectum, there was an exophytic mass with lobulated surface (a). On microscopic low power, a
submucosal neoplasm arranged in sheets, alveolar and rhabdoid patterns was seen (b). The neoplastic cells were pleomorphic having abundant
eosinophilic cytoplasm, enlarged hyperchromatic eccentric nuclei and prominent nucleoli (c). IHC stains were positive for PAX8 (d)
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in pancreatic head (Fig. 2a). Suspicion of a neuroendocrine tumor was raised. The patient had a history of right
radical nephrectomy performed 14 years ago which was
diagnosed as clear cell RCC, Fuhrman’s nuclear grade II
and staged pT1bNxMx. The tumor measured 5.5 × 5 × 4
cm. CT guided core needle biopsy of the pancreatic head
mass was performed and sent to us for histopathological examination. Grossly three linear cores were found.
Microscopically, a neoplastic lesion was seen. Tumor cells
were large with distinct cell borders, central round hyperchromatic nuclei, visible nucleoli and abundant clear
cytoplasm (Fig. 2b). Special stain PAS ± D reveal abundant cytoplasmic glycogen in the tumor cells. On IHC,
tumor cells expressed RCC, PAX8, CD10 and Vimentin
(Fig. 2c, d) and were negative for CK7 and CK20. Diagnosis of metastatic clear cell RCC was confirmed. Patient
refused further treatment. Seven months later, she developed shortness of breath and her condition deteriorated.
On admission, her chest x-ray showed pleural effusion
and infiltrates in both lungs suggestive of metastatic disease. She died after a week.
Cases 3 A 65-year-old man with a history of right
radical nephrectomy 11 years ago for a renal mass, was
on regular follow up with CT scan abdomen. The renal
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mass was measured as 9.5 × 5 × 4cm and was diagnosed
as clear cell RCC, Fuhrman’s nuclear grade II and staged
pT2aNxMx. Recently, the follow up CT scan revealed
single nodules in duodenum and pancreas. Metastatic
disease was suspected, and Whipple’s resection was
done, which consisted of part of stomach, duodenum,
pancreas and gallbladder. Grossly, a mass measuring
4 × 3.5 × 3.5 cm was found in duodenum while another
mass measuring 3 × 2.5 cm was identified in the pancreas. Representative sections from both nodules were
submitted for histopathological examination. Microscopic examination of both nodules revealed a neoplastic lesion arranged in nests and cords separated by thin
vascular septae. The neoplastic cells were polygonal in
shape with clear cytoplasm and rounded, hyperchromatic
nuclei. The cells were diffusely positive for cytoplasmic
glycogen highlighted on special stain PAS ± D. A panel
of IHC stains was performed. The neoplastic cells were
positive for CK AE1/AE3, CK Cam 5.2 and Vimentin
and negative for Chromogranin A, Synaptophysin and
S100. In view of clinical history, morphology and IHC
profile, diagnosis of metastatic clear cell RCC was made.
Patient died a week after surgery due to postoperative
complications.

Fig. 2 CT scan findings reveals a mass in pancreatic head (a). Microscopically, the tumor cells were large and have distinct cell borders with central
round hyperchromatic nuclei and abundant clear cytoplasm (b). IHC stains were positive for RCC (c) and PAX8 (d)
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Discussion
RCC is the most common type of renal neoplasms in
patients above 50 years of age. It is more common in
males with a male to female ratio of 2:1 [1]. In about
20–30% cases, primary RCC and its metastasis to the
distant organ will be diagnosed in the same time, which
is called synchronous presentation. 20% of RCC patients
with non-metastatic disease at diagnosis will later
develop metastases during follow-up (metachronous
presentation) [36].
In very rare cases of RCC, metastatic involvement of
GI tract can be observed. Metastasize to any part of GI
tract can occur but metastasis to colonic is much rarer
compared to gastric and to small intestine [37]. Colon
usually involved by metastatic cancers from breast, stomach and malignant melanoma of the skin [38]. RCC not
infrequently metastasizes to pancreas, RCC metastases
to pancreas account for 2–5% of all pancreatic neoplasms
and metastatic RCC is the most common secondary neoplasms in the pancreas followed by malignant melanoma
and colorectal carcinoma [39]. Metastasis of RCC to periampullary region is very rare and can occur several years
(6.5–12) after resection of primary renal tumor. Metastasis 32 years following previous resection has been
reported [40]. In these patients overall, 5-year survival
rates are less than 10% but surgical resection can improve
5-year survival rates up to 88%. Improvement in survival
is even seen in multi-focal metastasis [40]. A 5-year survival rate of 75% was reported in a retrospective study of
surgically treated pancreatic metastases in ten patients,
with the longest survivor at 117 months after resection.
Therefore, the study suggests that RCC metastasis to
pancreas should be managed aggressively with complete
resection [41]. European Association of Urology (EAU)
suggests that metastasectomy remained, by default, an
appropriate local treatment for most sites with the exception of brain and possibly bone metastases, which are frequently treated by stereotactic radiotherapy [42].
In our study, the time for metastases to pancreas following nephrectomy was 14 years in case 2 and 11 years
in case 3.
A study reported two cases of metastatic RCC in the
pancreas with mean time of metastasis of 41.5 months
(0–108). Both patients were males aged 65 and 87 years
[43]. RCC metastasis to colon can occur several years
following curative resection of the primary tumor or
it can occur soon after resection [44]. On reviewing
the reported cases of colon-rectal metastasis of RCC
(Table 1), one found that most colon metastases occurred
after 5 years (maximum 17 years). Only three cases
metastasized to colon within one year after resection of
primary RCC. Interestingly, all reported cases of metastatic RCC in colon occurred in males and all patients
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were over 50 years old (53–92 years), while in our case
metastatic RCC to colon occurred in a female patient who
was below 50 years of age (46 years). In addition, majority of reported metastatic RCC cases in colon presented
with rectal bleeding. Therefore, metastatic RCC should
be kept in mind in patients with known history of RCC
who presented with rectal bleeding. In our case, patients
presented with abdominal pain and constipation, probably be due to large size of the mass (11× 66 × 64 cm).
In our study, metastasis to pancreas and pancreaticoduodenal region occurred after 11 and 14 years after
resection of primary RCC.
In terms of appearance, we found in published literature cases of metastatic RCC in pancreas have been
mostly reported in men (75%) with average age of
65.5 years [41]. Metastases can occur through lymphatic
or hematogenous routes or by direct invasion. Large
tumor size increases the chances of metastatic spread.
However, metastases to lymph nodes and distant organs
can occur even in the early stages of RCC [45].
On literature review, not surprisingly, the most common metastatic type of RCC to GI tract is clear cell type,
the commonest RCC subtype [46]. However, papillary
type, chromophobe type and sarcomatoid type RCC
metastasizing to colon have been reported [37, 47, 48].
In our case, metastatic RCC in colon turned out to be
RCC with rhabdoid features. Among subtypes of RCC
the rhabdoid features is very rare account up to 5% of
all RCCs. RCC having rhabdoid features behave more
aggressively and usually develops extra renal invasion and
has higher potential for distant organ metastases comparing to other subtypes of RCC. Therefore, the prognosis of patients diagnosed RCC with rhabdoid features is
very poor [49].
Histologically, rhabdoid cells are characterized by large
polygonal cells with large amount pink-eosinophilic cytoplasm and having pleomorphic eccentric nuclei with visible large nucleoli. On IHC staining, rhabdoid cells show
positive reactivity with vimentin, epithelial membrane
antigen (EMA), cytokeratins and PAX8 but not reactive
for desmin, myoglobin, myogenin and Myo D1 [4, 50]. To
the best of our knowledge no case of metastatic RCC with
rhabdoid features has been reported in literature and our
case represents the first case of RCC with rhabdoid features metastasizing to colon. RCC with rhabdoid features
should be differentiated from other malignant tumors
having rhabdoid cell morphology. Alveolar Soft Part Sarcoma (ASPS) has the similar histologic morphology, the
cells are arranged in alveolar pattern and are polygonal
with eosinophilic granular cytoplasm. ASPS can rarely
occur or metastasize to colon. On IHC staining, Myo D1,
TFE3 and vimentin widely expressed among ASPS cells
[51], while these stains were not expressed in our case.
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Another malignant neoplasm which has the similar morphology is pleomorphic rhabdomyosarcoma. Pleomorphic rhabdomyosarcoma having large pleomorphic and
polygonal cells of rhabdomyoblasts. On IHC staining,
the neoplastic cells in pleomorphic rhabdomyosarcoma
show positive reactivity with myogenin, desmin, smooth
muscle actin (SMA) and vimentin. The cells of RCC with
rhabdoid features do not express these markers [52].
It is quite difficult to distinguish metastatic RCC having
rhabdoid features from ASPS and pleomorphic rhabdomyosarcoma only on histologic morphology. In our case,
IHC profile helped to diagnose the RCC with rhabdoid
features over ASPS and pleomorphic rhabdomyosarcoma. Our case was negative for TFE3, Myo D1, myogenin, desmin and positive for renal cell markers such as
PAX8 and Cam5.2. In addition, history of nephrectomy
and review of previous nephrectomy slides further supported the diagnosis of metastatic RCC with rhabdoid
features.
Metastasis to colon in the current study occurred in
less than one year following nephrectomy. This interval
is much shorter than in the literature. This is probably
because RCC with rhabdoid features is an aggressive type
of RCC with high potential for rapid early metastasis.
Few differential diagnoses should also be kept in mind
RCC metastasizing to pancreas. These include solid variant of serous cystadenoma of pancreas whose cells may
have clear cytoplasm and well-defined cell borders. However, hemorrhage and nuclear atypia are rare. In contrast,
metastatic RCC usually demonstrates foci of hemorrhage and nuclear atypia. Expression of PAX8 and CD10
by RCC cells is important for confirmation [53, 54]. It
should also be kept in mind that cases of metastatic RCC
to pancreas with underlying primary pancreatic microcystic serous cystadenoma have been reported and may
cause difficulty in identifying metastatic RCC [55]. In
such cases, careful microscopic evaluation along with
IHC staining can differentiate the two tumors as serous
cystadenoma cells do not express CD10 and PAX-8 and
RCC but are positive for CK7 while RCC cells are negative for CK7 and positive for CD10 and PAX-8. Solid
pseudo-papillary neoplasm (SPN) of the pancreas with
clear cell features is another entity that must be differentiate from metastatic RCC. However, this tumor occurs
mostly in young age and tumor cells are positive for synaptophysin and B-catenin [56].
PEComa should be also considered in differential diagnosis, although, it rarely occurs in pancreas and colon
but, the similar histologic morphology can be challengeable. PEComa has polygonal to round cells and are having clear cytoplasm. To surely differentiate it from RCC
with rhabdoid features, IHC staining is required. Tumor
cells in PEComa strongly express ASMA and HMB45
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stains while these IHC stains are negative for RCC cells
[57]. Radiology is of little significance in diagnosing skin
metastasis. However, metastasis of RCC to other locations can be recognized [58].
Histology is the gold standard for diagnosing metastasis and should be performed in all situations with adequate precautions. Light microscopy alone cannot help
much in differentiating metastatic RCC from other clear
cell tumors and IHC is required for accurate diagnosis
[59].

Conclusion
Metastatic RCC especially of clear cell subtype to the
colon and pancreas should be considered in the differential diagnosis especially if there is a previous history of
RCC or nephrectomy. Patients with lower GI symptoms
or mass, particularly those patients with the past history
of renal mass or nephrectomy should be screened thoroughly by physical examination and imaging modalities
for metastases to gastrointestinal tract (including pancreaticobiliary tract) and other locations.
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